| CVD | Cardiovascular disease |
| CAD | Coronary artery disease |
| PAD | Peripheral artery disease |
| CeVD | Cerebrovascular disease |
| MR | magnetic resonance |
| CCTA | Coronary computed tomography angiography |
| GWAS | Genome-wide association studies |
| AI | Artificial intelligence |
| XAI | Explainable artificial intelligence |
| FRS | Framingham risk score |
| SCORE | Systematic COronary Risk Evaluation |
| ACC/AHA | American College of Cardiology/American Heart Association |
| TIMI | Thrombolysis In Myocardial Infarction |
| GRACE | Global Registry of Acute Coronary Events |
| SMART | Secondary Manifestations of ARTerial disease |
| REACH | REduction of Atherothrombosis for Continued Health |
| CONFIRM | COronary CT Angiography EvaluatioN For Clinical Outcomes: |
| An InteRnational Multicenter registry | |
| GENIUS-CHD | Genetics of Subsequent Coronary Heart Disease |
| PRS | Polygenic risk score |
| LASSO | Least Absolute Shrinkage and Selection Operator |
| CNN | Convolutional neural networks |
| XGBoost | eXtreme Gradient Boosting |